This article explores the complex disease of diabetic cardiomyopathy (DCM), the main form of cardiac complications in diabetic patients, seriously affecting the quality of life and life expectancy of patients based on existing literature and data results. The results show that the pathophysiological mechanism of DCM is complex, involving multiple levels such as oxidative stress, inflammatory response, immune regulatory imbalance, and cardiometabolic abnormalities. In particular, the article emphasizes that insulin resistance not only affects glycolipid metabolism, but also significantly exacerbates the inflammatory response, and promotes cardiac fibrosis and functional decline by activating key mechanisms, such as the NLRP3 inflammasome, the NFκB positive feedback loop, and macrophage M1 polarization. The purpose of this article is to provide clinicians with the latest research on DCM and treatment recommendations, while also serving as a valuable reference for future research directions, emphasizing the importance of multidisciplinary collaboration in deepening the understanding of DCM and promoting its clinical management. In the face of DCM, continuous scientific research innovation and optimization of clinical practice are the keys to improving patient outcomes.
Research Article
Open Access